Pellucid: a hidden danger

Article

Clinicians should learn how to identify pellucid and screen patients for it prior to refractive surgery, according to Yaron Rabinowitz, MD, director of ophthalmology research, Cedars Sinai Medical Center, Los Angeles, USA.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Related Content
A teen boy or young adult man with a cane and sunglasses is walking happily next to a woman with curly hair. Concept image for NICE approval of Leber hereditary optic neuropathy therapy idebenone. Blindness vision loss and paediatric genetic eye disease. Mitochondrial inherited retinal disease. Image credit: ©Vane Nunes – stock.adobe.com

NICE announces UK approval of idebenone for treatment of Leber hereditary optic neuropathy

Hattie Hayes
August 7th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

August 7th 2025
Podcast
A computer screen with a lit-up brain on it. The computer is in a laboratory. Concept image of AI artificial intelligence use in glaucoma diagnosis and treatment.

Feasibility of artificial intelligence in leading glaucoma care

Lynda Charters
August 7th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

August 7th 2025
Podcast
An image of the planet Earth encircled by a DNA strand. Concept image for global inherited retinal disease research collaboration, Opus Genetics and RDH12 alliance. Image credit: ©JohanSwanepoel – stock.adobe.com

Opus Genetics, Global RDH12 Alliance announce new collaboration

Kassi Filkins
August 7th 2025
Article
Logos for Topcon Healthcare (left, black and purple) and Intelligent Retinal Imaging Systems (IRIS, right, blue and green). Concept image for diabetic eye disease retina screening company merger. Image courtesy of Topcon Healthcare.

Topcon expands AI portfolio with Intelligent Retinal Imaging Systems acquisition

Hattie Hayes
August 7th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.